GlassScriptPhysician profile
David J Dixon
NPI 1083681340
$3,605.74
in general payments reported to CMS, 2019-2025
12 companies · $301 in 2025
The $301 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $143 · 2020: $1,089 · 2021: $1,410 · 2022: $219 · 2023: $329 · 2024: $116 · 2025: $301.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $746.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $746.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $2,249.00 | 2020-2021 | |
| Treace Medical Concepts, INC. | $487.60 | 2023-2025 | |
| Stryker Corporation | $268.49 | 2019-2024 | T2, Inbone, Easyfuse |
| Prodigy Surgical Distribution, INC. | $184.00 | 2021 | |
| Depuy Synthes Sales INC. | $172.77 | 2019-2025 | Minibunion, Motoband |
| Nevro Corp. | $58.85 | 2022-2024 | Senza |
| Zimmer Biomet Holdings, INC. | $47.55 | 2019 | |
| Paragon 28, INC. | $46.35 | 2021-2022 | |
| Bioventus LLC | $38.33 | 2022-2024 | Exogen Ultrasound Bone Healing System |
| Integra Lifesciences Corporation | $19.57 | 2020 | |
| Olympus America INC. | $18.82 | 2023 | |
| Endo USA, INC. | $14.41 | 2025 | Xiaflex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Dixon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.